AlphaQuest LLC Makes New Investment in Axcelis Technologies, Inc. $ACLS

AlphaQuest LLC acquired a new stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) during the third quarter, HoldingsChannel reports. The fund acquired 13,793 shares of the semiconductor company’s stock, valued at approximately $1,347,000.

A number of other hedge funds also recently made changes to their positions in ACLS. American Century Companies Inc. raised its stake in Axcelis Technologies by 45.5% during the 2nd quarter. American Century Companies Inc. now owns 1,659,463 shares of the semiconductor company’s stock worth $115,648,000 after acquiring an additional 518,968 shares during the period. Reinhart Partners LLC. raised its position in shares of Axcelis Technologies by 6.0% during the 3rd quarter. Reinhart Partners LLC. now owns 1,610,332 shares of the semiconductor company’s stock valued at $157,234,000 after purchasing an additional 91,788 shares during the period. Primecap Management Co. CA lifted its stake in shares of Axcelis Technologies by 2.1% during the 2nd quarter. Primecap Management Co. CA now owns 852,296 shares of the semiconductor company’s stock valued at $59,397,000 after buying an additional 17,230 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in Axcelis Technologies by 2.4% in the 2nd quarter. Boston Trust Walden Corp now owns 845,911 shares of the semiconductor company’s stock worth $58,952,000 after buying an additional 19,579 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock worth $31,560,000 after buying an additional 44,275 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Stock Performance

NASDAQ ACLS opened at $88.07 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.95 and a quick ratio of 3.32. Axcelis Technologies, Inc. has a 1-year low of $40.40 and a 1-year high of $102.93. The business has a 50 day simple moving average of $87.51 and a two-hundred day simple moving average of $84.19. The stock has a market capitalization of $2.70 billion, a PE ratio of 20.82 and a beta of 1.73.

Axcelis Technologies (NASDAQ:ACLS) last posted its earnings results on Tuesday, November 4th. The semiconductor company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.20. Axcelis Technologies had a return on equity of 14.58% and a net margin of 15.93%.The firm had revenue of $213.61 million during the quarter, compared to the consensus estimate of $200.06 million. During the same period in the prior year, the company earned $1.49 EPS. The company’s quarterly revenue was down 16.8% compared to the same quarter last year. Axcelis Technologies has set its Q4 2025 guidance at 1.120-1.120 EPS. On average, research analysts predict that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Insider Activity

In other Axcelis Technologies news, EVP Gerald M. Blumenstock sold 3,034 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the sale, the executive vice president directly owned 18,661 shares of the company’s stock, valued at $1,669,413.06. The trade was a 13.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jorge Titinger sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $86.05, for a total value of $172,100.00. Following the sale, the director owned 7,477 shares in the company, valued at approximately $643,395.85. This trade represents a 21.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.48% of the company’s stock.

Analyst Upgrades and Downgrades

ACLS has been the topic of several research analyst reports. Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Zacks Research cut Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a report on Friday, December 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a report on Monday, December 22nd. Bank of America lifted their price objective on shares of Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a research report on Tuesday, January 13th. Finally, B. Riley boosted their target price on shares of Axcelis Technologies from $84.00 to $94.00 and gave the stock a “neutral” rating in a report on Wednesday, January 21st. Two analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $102.25.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.